Nasdaq:US$18.99 (+0.58) | HKEX:HK$30.35 (+1.05) | AIM:£3.04 (+0.08)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2012-10-14

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice